| Salvage therapy with single agent bevacizumab for recurrent glioblastoma MC Chamberlain, SK Johnston Journal of neuro-oncology 96 (2), 259-269, 2010 | 148 | 2010 |
| Stress exposure, psychological distress, and physiological stress activation in midlife women with insomnia JLF Shaver, SK Johnston, MJ Lentz, CA Landis Psychosomatic Medicine 64 (5), 793-802, 2002 | 135 | 2002 |
| Management of depression in rheumatoid arthritis: A combined pharmacologic and cognitive‐behavioral approach JC Parker, KL Smarr, JR Slaughter, SK Johnston, ML Priesmeyer, ... Arthritis Care & Research 49 (6), 766-777, 2003 | 122 | 2003 |
| High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma MC Chamberlain, SK Johnston Neuro-oncology 12 (7), 736-744, 2010 | 114 | 2010 |
| A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas JJ Raizer, SA Grimm, A Rademaker, JP Chandler, K Muro, I Helenowski, ... Journal of neuro-oncology 117 (1), 93-101, 2014 | 111 | 2014 |
| Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients JE Adair, SK Johnston, MM Mrugala, BC Beard, LA Guyman, AL Baldock, ... The Journal of clinical investigation 124 (9), 4082, 2014 | 100 | 2014 |
| Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas AL Baldock, S Ahn, R Rockne, S Johnston, M Neal, D Corwin, ... PloS one 9 (10), e99057, 2014 | 98 | 2014 |
| Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status AL Baldock, K Yagle, DE Born, S Ahn, AD Trister, M Neal, SK Johnston, ... Neuro-oncology 16 (6), 779-786, 2014 | 96 | 2014 |
| Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series MC Chamberlain, SK Johnston Journal of neuro-oncology 104 (3), 765-771, 2011 | 83 | 2011 |
| Hydroxyurea for Recurrent Surgery and Radiation Refractory Meningioma MC Chamberlain, SK Johnston NEUROLOGY 76 (9), A96-A96, 2011 | 83* | 2011 |
| Neoplastic Meningitis–Related Prognostic Significance of the Karnofsky Performance Status MC Chamberlain, SK Johnston, MJ Glantz Archives of neurology 66 (1), 74-78, 2009 | 81 | 2009 |
| Bevacizumab for recurrent alkylator‐refractory anaplastic oligodendroglioma MC Chamberlain, S Johnston Cancer 115 (8), 1734-1743, 2009 | 76 | 2009 |
| Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma MC Chamberlain, S Johnston Journal of neuro-oncology 91 (3), 359, 2009 | 65 | 2009 |
| Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab MC Chamberlain, SK Johnston Journal of neuro-oncology 102 (3), 427-432, 2011 | 58 | 2011 |
| Reliability and validity of the self-efficacy expectations and outcome expectations after implantable cardioverter defibrillator implantation scales CM Dougherty, SK Johnston, EA Thompson Applied nursing research 20 (3), 116-124, 2007 | 55 | 2007 |
| Temozolomide for recurrent intracranial supratentorial platinum‐refractory ependymoma MC Chamberlain, SK Johnston Cancer 115 (20), 4775-4782, 2009 | 53 | 2009 |
| Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology MC Chamberlain, SK Johnston Cancer 115 (9), 1941-1946, 2009 | 52 | 2009 |
| Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C MC Chamberlain, SK Johnston, A Van Horn, MJ Glantz Journal of neuro-oncology 91 (3), 271-277, 2009 | 42 | 2009 |
| Restraint reduction: a new philosophy for a new millennium B Jensen, A Hess-Zak, SK Johnston, DC Otto, L Tebbe, CL Russell, ... Journal of nursing administration 28 (7/8), 32-38, 1998 | 42 | 1998 |
| Quantifying Uncertainty and Robustness in a Biomathematical Model Based Patient-Specific Response Metric for Glioblastoma A Hawkins-Daarud, SK Johnston, KR Swanson bioRxiv, 325340, 2018 | 35 | 2018 |
